רבלימיד 15 מ"ג

Negara: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

LENALIDOMIDE 15 MG

Tersedia dari:

NEOPHARM SCIENTIFIC LTD

Kode ATC:

L04AX04

Bentuk farmasi:

CAPSULES

Rute administrasi :

PER OS

Diproduksi oleh:

CELGENE EUROPE LTD, UK

Kelompok Terapi:

LENALIDOMIDE

Indikasi Terapi:

1. Treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. In combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

Tanggal Otorisasi:

2009-04-01